Results

Total Results: 1,583 records

Showing results for "cancer".
Users also searched for: colon cancer screening

281. Colonic Diseases | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/health-topics/colonic-diseases
     April 02, 2014 - Archived August 9, 2013 Health Outcomes of Biologic Agents for Metastatic Colorectal Cancer … Archived January 19, 2010 Gene Expression Profiling for Predicting Outcomes in Stage II Colon Cancer … 14, 2012 Gene Expression Profiling for Predicting Outcomes in Patients With Stage II Colon Cancer … Research Protocol Archived March 5, 2012 Chemotherapy in Advanced Colorectal Cancer

282. Treatment of Stage I-III Squamous Cell Carcinoma (SCC) of the Anal Canal | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/anal-cancer-treatment

283. A-Z List of Health Topics | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/health-topics/salivary-gl-cancer

284. | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/health-topics/head-neck-cancer

285. | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/health-topics/cancer-in-children

286. Can screening among the general adult male population for elevated PCA3 (also known as DD3) gene expression, to identify those at risk for prostate cancer who may be candidates for prostate biopsy, reduce morbidity and mortality? | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/get-involved/nominated-topics/can-screening-among-the-general-adult-male-population-for-elevated-pca3-also-known-as-dd3-gene-expression-to-identify-those-at-risk-for-prostate-cancer-who-may-be-candidates-for-prostate-biopsy-reduce-morbidity-and-mortality
     July 29, 2010 - population for elevated PCA3 (also known as DD3) gene expression, to identify those at risk for prostate cancer … you would like to see compared: Use of commercially available PCA3 expression assays for prostate cancer … May lead to unnecessary follow-up for men who are asymptomatic or have slowly progressing prostate cancer … Prostate cancer is among the most frequently diagnosed and deadliest cancers among men in the U.S. … : Future Research Needs PCA3 Testing for the Diagnosis and Management of Prostate Cancer

287. ¿Es la prueba para detectar el cáncer pulmonar apropiada para mí? Herramienta para ayudarle a usted y a su profesional de atención médica a tomar decisiones (pdf file)
     effectivehealthcare.ahrq.gov/decision-aids/lung-cancer-screening/static/lung-cancer-screening-Spanish-encounter.pdf
     September 01, 2016 - ¿Es la prueba para detectar el cáncer pulmonar apropiada para mí? Herramienta para ayudarle a usted y a su profesional de atención médica a tomar decisiones ¿Es la prueba para detectar el cáncer pulmonar apropiada para mí? Herramienta para ayudarle a usted y a su profesional de atención médica a tomar decisiones S…

288. breast-biopsy-update-130920 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/breast-biopsy-update_research-protocol.pdf
     September 20, 2013 - is the second most common malignancy (after skin cancer), and the second most common cause of cancer … performance outcomes, as assessed by the following measures:  Sensitivity (proportion of cancerous tumors … Cosmetic results □ Quality of life □ Anxiety and other psychological outcomes □ Time to complete tumor … /di or exp breast neoplasms/di or exp breast disease/di or exp breast diseases/di 4 (breast or … or$ or lesion$ or cancer or carcinoma$ or lump$) 5 Combine sets or/2-4 6 Biopsy 5 and ((Biopsy or tumor

289. Breast-Biopsy Surveillance (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/breast-biopsy_surveillance.pdf
     July 01, 2012 - Women diagnosed with breast cancer by core-needle biopsy were usually able to have their cancer … Borderline breast lesions: comparison of malignancy underestimation rates with 14- gauge core needle … Surgical outcome of biopsy-proven lobular neoplasia: is there any difference between lobular carcinoma … OR exp breast cancer/di OR exp breast neoplasms/di OR exp breast disease/di OR exp breast diseases/di … Women diagnosed with breast cancer by core-needle biopsy were usually able to have their cancer treated

290. Epoetin and Darbepoetin for Managing Anemia in Patients Undergoing Cancer Treatment: Comparative Effectiveness Update | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/cancer-anemia-update/

291. Comparative Effectiveness of Fecal DNA Testing in Screening for Colorectal Cancer in Average Risk Adults | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/colorectal-cancer-screening/

292. Oral Contraceptive Use for the Primary Prevention of Ovarian Cancer | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/cancer-ovarian-contraceptives/

293. Comparative Effectiveness of Medications To Reduce Risk of Primary Breast Cancer in Women | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/breast-cancer-medications/

294. Imaging Tests for the Staging of Colorectal Cancer | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/colorectal-cancer-staging/

295. Imaging Techniques for Treatment Evaluation for Metastatic Breast Cancer | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/breast-cancer-imaging/

296. NIH State-of-the-Science Conference: Role of Active Surveillance in the Management of Men With Localized Prostate Cancer | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/prostate-cancer-surveillance/

297. Nutrition as Prevention for Improved Cancer Outcomes | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/improved-cancer-outcomes

298. Comparative Effectiveness of Therapies for Clinically Localized Prostate Cancer | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/prostate-cancer/research/

299. Comparative Effectiveness and Safety of Radiotherapy Treatments for Head and Neck Cancer | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/head-neck-cancer/

300. Patient Navigation Models for Lung Cancer | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/nav-model-lung-cancer/rapid-product
     December 11, 2018 - Patient Navigation Models for Lung Cancer Rapid Evidence Product December 11, 2018 Download Main Document … of patient navigation programs on lung cancer outcomes based on patient characteristics. … Only two completed studies evaluated the effectiveness of lung cancer patient navigation programs. … are important for lung cancer may be warranted. … Patient Navigation Models for Lung Cancer. Rapid Evidence Product.